期刊文献+

条件性SV40 TAg转基因小鼠模型的建立 被引量:2

Generation of conditional simian virus 40 large T antigen gene transgenic mouse model
下载PDF
导出
摘要 目的建立可调控的脑组织特异性表达SV40 TAg的转基因小鼠模型。方法构建由大鼠神经元特异性烯醇化酶基因(rat neuron-specific enolase,NSE)启动子驱动四环素基因表达调控系统的载体,从而控制SV40 TAg基因的表达;受精卵雄原核显微注射该线性化载体制备转基因小鼠;PCR方法鉴定首建鼠;RT-PCR方法检测小鼠组织中四环素反式激活子(rtTA)及SV40 TAg基因的表达情况。结果显微注射获得17个首建鼠,其中的6个首建鼠建系成功;1#、6#品系小鼠的脑组织中表达rtTA基因;强力霉素诱导后,可检测到6#品系小鼠脑组织中SV40TAg基因的特异性表达。结论可调控的脑组织表达SV40 TAg的转基因小鼠模型已经建立。 Objective To create a genetic mouse model with inducible expression of simian virus 40 large T antigen gene ( SV40 TAg) specifically in brain. Methods A single plasmid vector containing the regulatory element and TAg expression element of Tet-On expression system driven by rat neuron-specific enolase (NSE) promoter was constructed and micro-injected into the male pronuclei of fertilized ova from F1 hybrid mice (C57BL/6J × CBA). The founder mice were identified by PCR analysis. The expression of rtTA mRNA and SV40 TAg in different tissues were examined by RT-PCR. Results Seventeen founder mice carrying both rtTA and TAg genes were identified by PCR in which six Tet-On-NSE-T genetic transgenic mouse lines were successfully established. Expression of rtTA mRNA was detected in the brains of mice from line 1^# and 6^#. SV40 TAg mRNA was expressed in the brain tissue from mouse line 6^# after intraperitoneal injection of Doxycycline. Conclusion A genetic mouse model with inducible expression of SV40 TAg in brain was successfully established.
出处 《同济大学学报(医学版)》 CAS 2009年第3期29-33,共5页 Journal of Tongji University(Medical Science)
关键词 四环素基因表达调控系统 猿猴病毒40大T抗原基因 转基因小鼠 Tet-On expression system simian virus 40 large T antigen gene transgenic mouse
  • 相关文献

参考文献6

  • 1Frese KK,Tuveson DA.Maximizing mouse cancer models[J].Nat Rev Cancer,2007,7(9):645-658.
  • 2Carver BS,Pandolfi PP.Mouse modeling in oncologic preclinical and translational research[J].Clin Cancer Res,2006,12(18):5305-5311.
  • 3匡颖,梁斌,麻孙恺,王珏,费俭,王铸钢,毛积芳.SV40TAg转基因小鼠模型的建立及其表达[J].细胞生物学杂志,2006,28(6):873-878. 被引量:1
  • 4Bockamp E,Sprengel R,Eshkind L,et al.Conditional transgenic mouse models:from the basics to genome-wide sets of knockouts and current studies of tissue regeneration[J].Regen Med,2008,3(2):217-235.
  • 5Ishihara K,Oshimura M,Nakao M.CTCF-dependent chromatin insulator is linked to epigenetic remodeling[J].Mol Cell,2006,23(5):733-742.
  • 6Liu MJ,Liu ML,Shen YF,et al.Transgenic mice with neuron-specific overexpression of HtrA2/Omi suggest a neuroprotective role for HtrA2/Omi[J].Biochem Biophys Res Commun,2007,362(2):295-300.

二级参考文献16

  • 1Knudson AG Jr. Proc Natl Acad Sci USA, 1971, 68:820
  • 2Greenberg NM et al. Proc Natl Acad Sci USA, 1995, 92:3439
  • 3Garson K et al. J Soc Gynecol Investig, 2003, 10:244
  • 4Chailley-Heu B et al. J Pathol, 2001, 195:482
  • 5Brinster RL et al. Cell, 1984, 37:367
  • 6Fung KM et al. Lab Invest, 1994, 70:114
  • 7Bosse P et al. Oncogene, 1997, 14:2661
  • 8Sakimura K et al. Gene, 1987, 60:103
  • 9Oliva D et al. Genomics, 1991, 10:157
  • 10Chen J et al. Mol Pharmacol, 1998, 54:495

同被引文献40

  • 1Tentori L,Leonetti C,Scarsella M,et al.Systemic administration of GPI 15427,a novel poly(ADP-ribose) polymerase-1 inhibitor,increases the antitumor activity of temozolomide against intracranial melanoma,glioma,lymphoma[J].Clin Cancer Res,2003,9(14):5370-5379.
  • 2Calabrese CR,Almassy R,Barton S,et al.Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361[J].J Natl Cancer Inst,2004,96(1):56-67.
  • 3Curtin NJ.PARP inhibitors for cancer therapy[J].Expert Rev Mol Med,2005,7(4):1-20.
  • 4Tentori L,Graziani G.Chemopotentiation by PARP inhibitors in cancer therapy[J].Pharmacol Res,2005,52(1):25-33.
  • 5Bryant HE,Schultz N,Thomas HD,et al.Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase[J].Nature,2005,434(7035):913-917.
  • 6Farmer H,McCabe N,Lord CJ,et al.Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy[J].Nature,2005,434(7035):917-921.
  • 7Esteller M,Herman JG.Generating mutations but providing chemosensitivity:the role of O6-methylguanine DNA methyltransferase in human cancer[J].Oncogene,2004,23(1):1-8.
  • 8Middleton MR,Margison GP.Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway[J].Lancet Oncol,2003,4(1):37-44.
  • 9Esteller M,Garcia-Foncillas J,Andion E,et al.Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents[J].N Engl J Med,2000,343(19):1350-1354.
  • 10Cahill DP,Levine KK,Betensky RA,et al.Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment[J].Clin Cancer Res,2007,13(7):2038-2045.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部